 send to a friend by email
2022-02-22
The board of directors of Birzeit Pharmaceuticals Company BPC recommended to the general assembly, which will be holding a meeting in mid-April 2022, raising the paid-up capital from $20 million to $40 million through distributing one stock for each owned stock by shareholders, and distributing 10% cash dividends for the year 2021, to record dividends yield of 1.61% based on the current market price.
|
|
-trade
